Spots Global Cancer Trial Database for mtd
Every month we try and update this database with for mtd cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer | NCT01310478 | Colorectal Neop... | recombinant hum... | 17 Years - 70 Years | Fudan University | |
| Kanglaite Injection Phase I Study | NCT00031031 | Solid Tumors Re... Neoplasms | Kanglaite Injec... | 18 Years - | KangLaiTe USA | |
| An Investigation of TAS-119 Monotherapy | NCT02448589 | Advanced Solid ... | TAS-119 | 18 Years - | Taiho Oncology, Inc. | |
| Treatment of MB07133 Plus Sintilimab in Patients With Hepatocellular Carcinoma | NCT06141109 | Safety Issues Efficacy MTD | Sintilimab 200m... | 18 Years - 70 Years | Xi'an Xintong Pharmaceutical Research Co.,Ltd. | |
| Study of BGB-11417 in Adult Participants With Mature B-cell Malignancies | NCT04883957 | Mature B-cell M... | BGB-11417 | 18 Years - | BeiGene | |
| Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102) | NCT00986843 | Advanced Solid ... | HM30181AK table... | 19 Years - | Hanmi Pharmaceutical Company Limited | |
| Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer | NCT01310478 | Colorectal Neop... | recombinant hum... | 17 Years - 70 Years | Fudan University | |
| A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer | NCT01589419 | Locally Advance... | veliparib capecitabine radiation | 18 Years - 99 Years | AbbVie | |
| A Study of Oraxol® in Gastric Cancer Patients | NCT01491217 | Advanced Metast... Recurrent Gastr... | Paclitaxel | 19 Years - | Hanmi Pharmaceutical Company Limited | |
| Temsirolimus in Combination With Metformin in Patients With Advanced Cancers | NCT01529593 | Advanced Cancer... | Temsirolimus Metformin | 14 Years - | M.D. Anderson Cancer Center | |
| Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs) | NCT01364415 | Neuroendocrine ... | Pasireotide LAR | 18 Years - | Novartis | |
| Phase I Trial to Investigate Cafusertib Hydrochloride in Combination With Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML) | NCT02140606 | Leukemia, Myelo... | Cafusertib Hydr... | 18 Years - | Jiangsu Hansoh Pharmaceutical Co., Ltd. | |
| Sorafenib Plus S-1 in Advanced Solid Tumors | NCT01128998 | Advanced Solid ... | Sorafenib S-1 | 20 Years - 75 Years | National Health Research Institutes, Taiwan | |
| A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF | NCT01787552 | Primary Myelofi... Thrombocytosis Essential Throm... Polycythemia Ve... Myeloproliferat... Bone Marrow Dis... Hematologic Dis... Blood Coagulati... Blood Platelet ... Hemorrhagic Dis... | LDE225 INC424 | 18 Years - | Novartis | |
| Dose-Escalation Study in Advanced Colon Cancer Patients | NCT00969046 | Colon Cancer | EPO906 (patupil... | 18 Years - | Novartis | |
| Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia | NCT01794702 | Leukemia | Decitabine Idarubicin Cytarabine Clofarabine | 18 Years - 64 Years | M.D. Anderson Cancer Center | |
| A Study of TAS-116 in Patients With Solid Tumors | NCT02965885 | Advanced Solid ... | TAS-116 | 18 Years - | Taiho Oncology, Inc. | |
| Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma | NCT00316511 | Malignancies B-Cell Lymphoma | Aroplatin | 18 Years - | Agenus Inc. | |
| A Trial of TAS-114 in Combination With S-1 | NCT02454062 | Advanced Solid ... | TAS-114 S-1 | 18 Years - | Taiho Oncology, Inc. | |
| Ruxolitinib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) | NCT01895842 | Leukemia | Ruxolitinib | 18 Years - | M.D. Anderson Cancer Center | |
| Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102) | NCT00986843 | Advanced Solid ... | HM30181AK table... | 19 Years - | Hanmi Pharmaceutical Company Limited | |
| Maximum Tolerated Dose, Safety and Pharmacologic Study of TRF in Women With Breast Cancer | NCT03855423 | Breast Cancer F... | Tocotrienol-ric... | 18 Years - | University of Malaya | |
| A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors | NCT06292208 | MTD | IBD0333 | 18 Years - 80 Years | SUNHO（China）BioPharmaceutical CO., Ltd. | |
| Phase I Trial to Investigate Cafusertib Hydrochloride in Combination With Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML) | NCT02140606 | Leukemia, Myelo... | Cafusertib Hydr... | 18 Years - | Jiangsu Hansoh Pharmaceutical Co., Ltd. | |
| A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities | NCT03410927 | Advanced Solid ... Advanced Solid ... | TAS0728 | 18 Years - | Taiho Oncology, Inc. | |
| Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric Junction | NCT01042782 | Advanced Gastri... Advanced Cancer... | RAD001 and Mito... | 18 Years - | Krankenhaus Nordwest | |
| Safety, Tolerability and Pharmacokinetics of DCBCI0901 in Patients With Advanced Solid Tumor | NCT02151357 | Cancer | DCBCI0901 | 20 Years - 80 Years | Standard Chem. & Pharm. Co., Ltd. | |
| Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST) | NCT04138381 | Maximum Tolerat... GIST Metastatic Adul... Drug Toxicity Drug Use | Selinexor Imatinib | 18 Years - | Grupo Espanol de Investigacion en Sarcomas | |
| An Investigation of TAS-119 Monotherapy | NCT02448589 | Advanced Solid ... | TAS-119 | 18 Years - | Taiho Oncology, Inc. | |
| Study of BGB-11417 in Adult Participants With Mature B-cell Malignancies | NCT04883957 | Mature B-cell M... | BGB-11417 | 18 Years - | BeiGene | |
| A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas. | NCT05878691 | Advanced Solid ... Lymphoma | GRC 54276 GRC 54276 + Pem... GRC 54276 + Ate... | 18 Years - | Glenmark Specialty S.A. | |
| A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors | NCT06292208 | MTD | IBD0333 | 18 Years - 80 Years | SUNHO（China）BioPharmaceutical CO., Ltd. | |
| A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy | NCT03612466 | Osteosarcoma Bone Metastases | 153Sm-DOTMP External beam r... Calcium Carbona... Mozobil Neupogen Inject... | 15 Years - 65 Years | Albert Einstein College of Medicine | |
| Ruxolitinib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) | NCT01895842 | Leukemia | Ruxolitinib | 18 Years - | M.D. Anderson Cancer Center | |
| An Investigation of TAS-119 Monotherapy | NCT02448589 | Advanced Solid ... | TAS-119 | 18 Years - | Taiho Oncology, Inc. | |
| Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome | NCT01893320 | Leukemia | Vosaroxin Decitabine | 60 Years - | M.D. Anderson Cancer Center | |
| Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma | NCT00316511 | Malignancies B-Cell Lymphoma | Aroplatin | 18 Years - | Agenus Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
